louisiana glp-1 class action drugs could become personalized for individuals, new study says glp-1_analogs [TUSOM | Pharmwiki]

Kimberly Anne Gudzune of @HopkinsMedicine, recorded @SocietyGIM #SGIM23 in Denver, Colorado Show Segments Intro Barriers to treating medicine in primary care Patient counseling and obesity pathophysiology Motivational Interviewing Telemedicine for obesity Tools and tips for a weight loss program Medications for Obesity GLP1 agonist prescribing tips Outro Obesity Medicine Pearls Obesity is a chronic disease

It is important to note that every individual will respond differently, and intermittent fasting is not right for everybody

Every day, some cells expire and new ones replace them

Doses above 2ml per injection show diminishing returns: a 2019 study published in the Journal of Clinical Endocrinology found no additional improvement in hepatic fat fraction when methionine doses exceeded 50mg per injection, and injection site soreness increased proportionally above this threshold